Background: Gemcitabine has been shown to be effective as a single agent in a variety of tumors including nonHodgkin's lymphoma. Its use in veterinary medicine has been limited and to date this drug has not been used as a first-line therapy in dogs with lymphoma.
Hypothesis: Gemcitabine as a single agent may be efficacious in dogs presented for the first time with lymphoma.